WASHINGTON (AP) - The Food and Drug Administration says a Medtronic nerve stimulating implant failed to significantly reduce seizures in epilepsy patients.
Medtronic Inc. has asked the FDA to approve its Deep Brain Stimulation implant for epilepsy, a neurological disease that causes seizures.
The device is already used to treat other movement disorders, including Parkinson's Disease.
In documents posted online, the FDA says Medtronic's device failed to meet its primary study goal, which was a reduction in seizures after three months in patients with the device compared to those without it.
After Medtronic completed the study, the FDA says the company re-analyzed the data to show a significant reduction.
The FDA will ask a panel to weigh those results this Friday.
Web Search powered by YAHOO!
|
LifestylesLifestyles
FDA: Medtronic brain stimulator missed study goal
WASHINGTON (AP) - The Food and Drug Administration says a Medtronic nerve stimulating implant failed to significantly reduce seizures in epilepsy patients.
By:
|
WNCT
Published: March 10, 2010
Published: March 10, 2010
Email
Facebook
Google
Twitter
Favorites
MoreAdvertisement
View More:
Deep Brain Stimulation,
Epilepsy,
Food And Drug Administration,
Health_Medical_Pharma,
Medtronic Inc.,
Movement Disorders,
Neurological Disease,
Parkinson's Disease,
Seizures,
Washington
Not what you're looking for? Try our quick search:
Reader Comments
*Facebook Account Required to Comment. If you are not already logged into Facebook, please click the comment button to do so.Deal of the Day
Advertisement
Interactive Radar
Advertisement
Featured Blogger
Reel Reviews
Updated: 02/10/2012
Nine On Your Side's Phillip Sayblack shares his take on the latest movie and dvd releases.
More Posts by Reel Reviews
Hot Topics on WNCT.com
Advertisement
Advertisement